Table 2 Use of software reported in the systematic reviews
Total (n = 152) | Cochrane (n = 75) | Non-Cochrane (n = 77) | |
|---|---|---|---|
Software used for study selection | |||
Covidence | 18 (12%) | 16 (21%) | 2 (3%) |
DistillerSR | 2 (1%) | 0 (0%) | 2 (3%) |
EndNote | 11 (7%) | 5 (7%) | 7 (9%) |
Microsoft Excel | 2 (1%) | 1 (1%) | 1 (1%) |
Rayyan | 2 (1%) | 0 (0%) | 2 (3%) |
Other | 3 (2%) | 1 (1%) | 2 (3%) |
None reported | 122 (80%) | 58 (77%) | 64 (83%) |
Software used for data extraction | |||
Covidence | 9 (6%) | 8 (11%) | 1 (1%) |
DistillerSR | 2 (1%) | 0 (0%) | 2 (3%) |
Microsoft Excel | 3 (2%) | 2 (3%) | 1 (1%) |
Other | 4 (3%) | 1 (1%) | 3 (4%) |
None reported | 133 (88%) | 63 (84%) | 70 (91%) |
Software used for statistical analysis | |||
Comprehensive Meta-Analysis | 6 (4%) | 0 (0%) | 6 (8%) |
R | 10 (7%) | 0 (0%) | 10 (13%) |
RevMan | 100 (66%) | 73 (97%) | 27 (35%) |
Stata | 18 (12%) | 2 (3%) | 16 (21%) |
Trial Sequential Analysis (TSA) | 4 (3%) | 2 (3%) | 2 (3%) |
Other | 7 (5%) | 2 (3%) | 5 (6%) |
None reported | 20 (13%) | 2 (3%) | 18 (23%) |
Software used for grading of evidence | |||
GRADEpro GDT | 72 (47%) | 70 (93%) | 2 (3%) |
No software use reported | 12 (8%) | 0 (0%) | 12 (16%) |